ARTICLE | Finance
More dry powder for Newpath’s company creation strategy
Boston firm to build portfolio of 8-12 biotechs with $350M second fund
December 11, 2021 1:06 AM UTC
With seven biotechs launched through its debut fund, Newpath is looking to expand its portfolio of academic-driven start-ups with its $350 million second fund.
Newpath Partners’ new vehicle is nearly double the size of its $187 million Newpath Partners Fund I, which closed in 2018...